Valuation: NanoSphere Health Sciences Inc.

Market Cap 184K 168K 155K 140K 263K 17.17M 275K 1.87M 743K 9.28M 690K 675K 29.39M P/E 2024
1.22x
P/E 2025 -2.21x
Enterprise Value 245K 224K 207K 187K 351K 22.91M 368K 2.5M 992K 12.38M 921K 901K 39.22M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
67.71%
Yield 2024 *
-
Yield 2025 -
1 month+25.00%
3 months+25.00%
6 months+25.00%
1 month 0.02
Extreme 0.02
0.02
Current year 0.02
Extreme 0.02
0.03
1 year 0.02
Extreme 0.02
0.03
3 years 0
Extreme 0.005
0.18
5 years 0
Extreme 0.005
0.29
10 years 0
Extreme 0.005
23.2
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 2012-12-31
Director of Finance/CFO 33 2017-10-31
Chief Executive Officer - -
Director TitleAgeSince
Chairman 74 2019-07-09
Director/Board Member - 2017-11-16
Director/Board Member - 2017-11-16
Date Insider Type Main position Quantity % Market Cap. Importance
9/17/21 Other

Director

0 0.0000%
9/17/21 Other

Director

0 0.0000%
9/17/21 Sell

Chairman

338,956 6.2564%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%+66.67% 179K
-1.91%-5.05%+29.12%+126.78% 1,232B
-2.37%-5.98%+31.63%+77.82% 656B
-1.13%-3.79%+21.63%+104.82% 506B
-1.04%-1.80%+28.69%+68.33% 382B
-4.08%-9.77%+39.50%+29.13% 340B
-3.22%-5.20%+24.48%+50.97% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-0.72%-5.74%+28.58%+65.91% 240B
-1.21%-0.54%+30.44%+119.80% 210B
Average -1.73%-2.07%+23.19%+74.19% 414B
Weighted average by Cap. -1.92%-2.67%+27.02%+87.24%

Financials

2024 2025
Net sales - -
Net income 263K 240K 222K 201K 377K 24.59M 394K 2.68M 1.06M 13.29M 988K 967K 42.1M -84.78K -77.24K -71.51K -64.68K -121K -7.92M -127K -864K -343K -4.28M -318K -311K -13.55M
Net Debt 28.69K 26.14K 24.2K 21.89K 41.06K 2.68M 42.97K 292K 116K 1.45M 108K 105K 4.59M 61.51K 56.04K 51.88K 46.93K 88.03K 5.74M 92.14K 627K 249K 3.1M 231K 226K 9.83M
Projected Income Statement - Annual - NanoSphere Health Sciences Inc.
Logo NanoSphere Health Sciences Inc.
NanoSphere Health Sciences Inc. is a nano-biotechnology company focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company's NanoSphere Deliver System is a platform that uses nanotechnology in the bio delivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and others. The Company's subsidiaries include NanoSphere Health Sciences, LLC, and Nanosphere Cannabis International Inc. NanoSphere Health Sciences, LLC is the Company’s operating division in the United States.
Employees
-
Date Price Change Volume
26-11-10 $0.000000 - 187
  1. Stock Market
  2. Stocks
  3. NSHS.X Stock